Trial Profile
Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Cisplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 03 Apr 2012 Planned end date changed from 1 Jul 2012 to 1 Jul 2014 as reported by ClinicalTrials.gov.
- 03 Aug 2010 New trial record